Indicators

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >

Cramer's Lightning Round: Apple is a buy

May 28, 2024

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

May 23, 2024

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations

April 29, 2024

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

April 25, 2024

5 things to know before the stock market opens Monday

April 22, 2024

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

April 09, 2024

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

March 01, 2024

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

February 13, 2024

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

February 08, 2024

Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch

February 02, 2024

Bristol Myers Squibb results top estimates as new drugs post strong sales growth

February 02, 2024

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

January 30, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

January 28, 2024

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

January 26, 2024

Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'

January 08, 2024

Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care

January 08, 2024

Cramer names biopharma companies to watch as industry mergers start to pile up

January 05, 2024

Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference

January 05, 2024

Biden administration's Medicare drug price negotiations will face major tests in 2024

December 28, 2023

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

December 22, 2023

Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios

December 18, 2023

Pfizer shares fall as 2024 revenue and profit forecast disappoints

December 13, 2023

Jim Cramer explains why it's hard to be bullish on the healthcare sector

November 30, 2023

Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest

October 30, 2023

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

October 26, 2023

Cramer's Lightning Round: Sell Fisker

October 23, 2023

5 things to know before the stock market opens Monday

October 23, 2023

Top Wall Street analysts favor these five dividend stocks during tumultuous times

October 22, 2023

Drugmakers opt in to Medicare drug price negotiations – here's what happens next

October 02, 2023

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.